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CASE SERIES
Case series of rare Interstitial Lung Disease (ILD)
Naveed Haroon Rashid, Saba Farooq, Mohammad Ahmed, Ali Bin Sarwar Zubairi

Abstract
Pulmonary alveolar proteinosis (PAP) is a rare lung disease
where periodic acid Schiff (PAS)-positive eosinophilic
material accumulates in the alveoli of the lungs. Here we
describe two cases of young males who presented with
dynpnoea and weight loss. The HRCT scan of the chest in
both cases showed the typical "crazy-paving" pattern and
lung biopsies confirmed the diagnosis of PAP. They
showed remarkable symptomatic improvement with
therapeutic whole lung lavage.
Keywords: Pulmonary Alveolar Proteinosis, Dyspnea,
Whole Lung Lavage.

Introduction
Pulmonary Alveolar Proteinosis (PAP) was first described
in 1958 as a disease of the lung that consists of the filling
of the alveoli by a PAS-positive proteinaceous material
rich in lipid.1 It is a rare disease with the incidence of one
case in every two million people. It is predominately
found in males with a male to female ratio of 3:1.2

lung periphery. This pattern is identified as crazy-paving
pattern.6 Positive findings on both HRCT and BAL
(brochoalveolar lavage) studies provide a high diagnostic
accuracy. A transbronchial or surgical lung biopsy is the
definitive diagnostic test for PAP.3

Case Presentations
Case 1
A nineteen-year old male, non-smoker, presented to the
pulmonology clinic in February 2014 with a one and halfyear history of dyspnoea on exertion and right sided chest
pain. He reported one episode of haemoptysis and a
significant weight loss of 15 kg over the past year. There
was no history of cough, orthopnoea, fever, night sweats
or cyanosis.
He was treated for probable tuberculosis for 9 months,
although the sputum studies were negative for acid fast
bacilli. There was no significant family history. He was a

PAP is subcategorized into three types; congenital,
secondary and acquired.Congenital PAP is related to
mutations in the genes for surfactant and/or GM-CSF
receptor. Acquired PAP is due to autoimmune production
of anti-GM-CSF antibodies. Secondary PAP is attributable
to multiple underlying conditions like infections,
pneumoconioses,
haematologic
malignancies,
immunodeficiency and autoimmune disorders. The
disease process leads to accumulation of the
lipoproteinaceous substances in the alveoli which
compromise the gaseous exchange in the lungs.3,4
The disease presents with a wide array of symptoms but
may be asymptomatic. Symptoms may include persistent
dry cough, progressive dyspnoea, generalized weakness,
malaise, weight loss, intermittent low-grade fever,
pleuritic chest pain and rarely cyanosis and haemoptysis.5
A typical radiological picture of PAP on HRCT scan of the
chest shows bilateral, patchy perihilar and infrahilar
idiosyncratic ground-glass opacities with sparing of the
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Figure-1: Chest radiograph of Case 1 shows bilateral interstitial lung infiltrates in a
"bat-wing" pattern.
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Figure-3: Histological section from open lung biopsy of Case 1: Alveolar
Lipoproteinosis; The alveoli are filled with finely granular material with a cholesterol
cleft (arrow) 20x10; Haematoxylin and Eosin stain.
Figure-2: Chest HRCT of Case 1 shows extensive areas of ground glass opacities with
interlobular septa thickening.

tailor by profession. There was no history of drug allergies
or illicit drug use.
Clinically he appeared comfortable. His general physical
examination and vital signs were within normal limits. On
chest examination, maculopapular blanching rash was
noted over the posterior chest and fine end-inspiratory
crackles were heard on the posterior lower one-third of
the chest. The rest of the physical examination was within
normal limits.
The lab tests including complete blood counts, HIV
screening and autoimmune workup was normal. The
chest x-ray showed bilateral perihilar infiltrates (Figure-1).
A high-resolution computed tomography scan showed
characteristic areas of patchy ground-glass opacifications
with interlobular septal thickening and intralobular
reticular thickening (Figure-2).
The broncho-alveolar lavage [BAL] was negative for gramstain and acid-fast bacilli and few macrophages were seen
on cytology. A transbronchial lung biopsy revealed focal
histiocytes which highlighted with CD 68 immunostain,
with surrounding haemorrhage. An open lung biopsy was
performed for confirmation of the diagnosis (Figure-3).
The histopathology revealed lung tissue exhibiting
variable sized lung alveoli containing amorphous

eosinophilic material. Some of the alveoli also showed
foamy histiocytes, hemorrhage and cholesterol clefts. The
diagnosis of PAP was made. He underwent therapeutic
alveolar lavage with 12 liters of normal saline in each lung.
On follow up visit the patient had improved significantly
and dyspnoea had almost completely resolved.

Case 2
A 24 year old male, non-smoker was referred to our
hospital from Defense Military Hospital in Bahrain in
October 2014. He presented with a 5 month history of
dyspnoea and undocumented weight loss. The HRCT
scan of the chest showed the classic "crazy paving"
pattern (Figure-4) and he was diagnosed to have PAP on
a transbronchial lung biopsy. Autoimmune markers and
HIV testing were negative.
He received several courses of Prednisolone for over 5
months with dosages ranging between 40-60 mg per day
and had progressively developed the need for
supplementary oxygen over the past year. He was now on
ambulatory oxygen of 2 liters per hour and had also
developed polycythemia. He had no significant past
medical or family history. There was no history of drug
allergies or illicit drug use.
He was in respiratory distress with a respiratory rate of 28
breaths per minute and oxygen saturation of 88% on 2
liters of oxygen per minute. He was using his accessory
J Pak Med Assoc
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revealed the classic "crazy paving" pattern in our patients.
In the presence of hypoxia or respiratory distress as was
the case with both our patients the treatment of choice is
a whole lung lavage with a double-lumen endotracheal
tube.7 It was performed under general anaesthesia and
before the lavage was started 100% oxygen was used for
ventilation. The solution used was isotonic sodium
chloride; which is considered the ideal choice of fluid in all
cases of PAP. The amount of solution used for whole lung
lavage is dependent on the series of washouts. A clear
lavage is indicative of a successful washout (Figure-5). We
used 12-20 liters per lung but up to 50 liters of fluid per
lung can be used safely for the lavage. Both the lungs
were lavaged 24 hours apart in our patients.

Figure-4: Chest HRCT scans of Case 2: These images show a symmetric combination of
extensive ground-glass opacities and interlobular septa thickening in posterior areas of
the lungs.

Figure-5: Whole Lung Lavage washouts of case 2. The image displays the fluid
aspirate in the series of lung lavages from a patient with PAP.

muscles of respiration and had a pulse of 110 beats per
minute. Rest of the general physical examination was
normal. On chest auscultation there were decreased
breath sounds bilaterally and mid-inspiratory crackles
were present across both the lung fields. The
cardiovascular, abdominal and CNS examinations were
unremarkable.
He underwent therapeutic lung lavage with 11 Liters in
the right lung and 18 liters in the left lung (Figure-5). His
condition improved significantly upon discharge and on
follow up he had oxygen saturation of 98% on room air.

Discussion
PAP has a variable presentation and disease course. The
chest radiographs are usually non-specific and showed
prominent interstitial infiltrates in our patients. The HRCT
Vol. 67, No. 5, May 2017

The outcome of our patients was excellent, as it usually is
for primary PAP. Our first case showed complete
remission and resolution of symptoms following whole
lung lavage, while the second case showed dramatic
improvement in symptoms and was weaned off the
oxygen.
Although there is a lack of randomized controlled clinical
studies, evidence shows that response rates are around
60%, less than 15% cases require lavage every 6 months
and less than 10% of cases fail to respond.7 Research also
suggests that patients who require repeat lavages usually
have progression to pulmonary fibrosis.7 This treatment
modality however is both time-intensive and requires
technical skills.
A relatively novel approach of using GM-CSF therapy in
the treatment of pulmonary alveolar proteinosis in
humans is being studied after murine studies showed
resolution of a PAP-like syndrome in mice with GM-CSF
deficiency on administration of local GM-CSF therapy.8
However up till now only a few human cases have been
reported in literature to have shown response to this
treatment.9 The exact mechanism of action of this therapy
is yet to be determined and proper treatment guidelines
need to be established.

Conclusion
PAP is a rare disorder which is usually seen in young
otherwise healthy patients. This condition may present
with a spectrum of symptoms and can be a diagnostic
challenge. It is imperative to determine which patients
require extensive workup including diagnostic tools such
as HRCT and open lung biopsy which is considered the
gold standard for diagnosis.
Treatment options are limited. Whole lung lavage has
produced excellent results, with most patients
experiencing almost complete remission post lavage.
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Further evidence is required to establish GM-CSF as an
alternative or an adjunct to whole lung lavage in the
treatment of PAP.
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